Experimental Models of Ischaemia-Reperfusion Injury: Animal Species, Organ-Specific Approaches, Molecular Biomarkers and Therapeutic Targets
Journal of Laboratory Animal Science and Practices, cilt.6, sa.2, ss.193-205, 2026 (Hakemli Dergi)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 6 Sayı: 2
- Basım Tarihi: 2026
- Doi Numarası: 10.62425/jlasp.1980645
- Dergi Adı: Journal of Laboratory Animal Science and Practices
- Sayfa Sayıları: ss.193-205
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Ondokuz Mayıs Üniversitesi Adresli: Evet
Özet
Ischaemia and reperfusion (I/R) injury results from the combined effects of restricted tissue
perfusion and potentially damaging consequences of blood flow restoration. Experimental
animal models are essential for investigating the cellular and molecular events underlying
I/R injury; however, their outcomes are strongly influenced by the species, target organ,
method and duration of vascular occlusion/ligation/clamping, reperfusion interval,
anaesthetic protocol, sampling time, and analytical approach. This narrative review
examines commonly used cardiac, cerebral, hepatic, renal, intestinal, pulmonary, spinal
cord, and skeletal-muscle I/R models, with emphasis on their methodological characteristics
and translational limitations. It also critically evaluates biomarkers and mechanistic
endpoints associated with oxidative and nitrosative stress, inflammation, mitochondrial
dysfunction, ionic dysregulation, autophagy, apoptosis, necroptosis, pyroptosis, and
ferroptosis. Conventional measures—including malondialdehyde, antioxidant-enzyme
activities, cytokines, caspases, and histopathological scores—remain widely used but often
lack organ specificity and are highly dependent on sampling time and assay methodology.
Emerging approaches based on microRNAs, metabolomics, proteomics, lipidomics, and
mitochondrial functional measurements may improve mechanistic resolution, although
most candidate markers require independent and cross-species validation. Reliable
interpretation therefore requires the integration of molecular, biochemical, functional, and
histological outcomes rather than reliance on a single marker. Greater standardisation of
experimental design, transparent reporting, and incorporation of animal welfare and bias-
reduction measures are necessary to improve reproducibility and clinical translation.